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Background: Obsessive-compulsive disorder (OCD) in patients with psychotic disorders has been reported to be a
frequent co-morbid disorder in patients with psychotic disorders. The aim of the study determine the prevalence of
OCD in first-episode psychosis and the relationship with clinical characteristics.
Methods: First-episode psychosis patients (N = 246) consecutively admitted to a comprehensive early psychosis
program were assessed for OCD with the Structured Clinical Interview for DSM-IV. Symptom assessment measures
were the Positive and Negative Syndrome Scale, Global Assessment of Functioning, and the Clinician Rating Scale.
Results: Twenty-six patients (10.6%) fulfilled the criteria for OCD. Patients with comorbid OCD were younger, had
more depressive symptoms and a higher rate of suicidal plans or attempts at index point compared to patients
without OCD. The two groups did not differ with respect to other demographic variables or severity of psychotic
symptoms.
Conclusion: OCD is a significant comorbid disorder in patients with first-episode psychosis. Since treatment
procedures are different, systematic screening for OCD is warranted.
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The existence of comorbid OCD in patients with psych-
otic disorders has been recognised for over a century, but
the reports have been less consistent with regard to the
extent of the comorbidity and the influence on the clinical
expression. Comorbidity rates are in general reported to
be higher than the prevalence in the general population.
In a recent meta-study Achim et al. estimated comorbidity
rates for OCD in patients with schizophrenia at 12% [1].
Several studies have proposed that comorbid OCD affect
the clinical expression of patients with psychotic disorders.
Comorbid OCD is related to more impairmed social func-
tioning [2,3] and more neurological abnormalies [4-6].
Patients with schizophrenia and comorbid OCD have been
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reproduction in any medium, provided the orincreased rate of depressive symptoms and suicidal
attempts [7-9], compared to their non-OCD counterparts.
However, these patterns have not been constantly reported
[10,11].
Most studies of comorbid OCD in psychotic disorders
have been conducted on patients with schizophrenia in
large psychiatric institutions or day treatment centres.
The samples often consist of chronic patients, which
introduce several limitations related to the effects of ill-
ness duration, institutionalisation, and aggravation or in-
duction of second-onset OCD during antiserotonergic
antipsychotics [12-14]. To increase the understanding of
comorbid OCD in psychosis, there is a need for studies
where these methodological challenges are met.
The present report is from a representative and relatively
large sample of patients with first-episode psychosis (FEP),
recruited in a population-based catchment area in an early
phase of the psychotic disorder. The primary aim was to in-
vestigate the prevalence of OCD in the FEP-patients, with
strict diagnostic methodology. The secondary aim was toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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differed from the patients without OCD on socio-
demographic characteristics, type of psychotic disorder,
general functioning, and severity of positive and nega-
tive symptoms at the start of treatment.Method
Participants
This study included patients in the Catchment area for
Stavanger University Hospital, division of psychiatry in the
South sector of Rogaland County, Norway, with a popula-
tion of about 270 000, mainly in urban and suburban
areas. Recruitment for the study continued consecutively
from January 1, 2002 to November 30th, 2010. The criteria
for inclusion in the study were 1) Living in the catchment
area; 2) age 15–65 years; 3) meeting the DSM-IV [15]
criteria for first episode schizophrenia, schizophreniform
psychosis, schizoaffective psychosis, delusional disorder,
brief psychosis, affective disorder with mood incongruent
delusions, or psychosis not otherwise specified, and also
from August 1, 2008 Substance induced psychosis; 4) be-
ing actively psychotic, as measured by a score at the Posi-
tive and Negative Syndrome Scale (PANSS) [16] of four or
more on at least one of the following PANSS items; P1
(delusions), P3 (hallucinations), P5 (grandiose thinking),
P6 (suspiciousness) and A9 (unusual thought content); 5)
not previously receiving adequate treatment for psychosis
(defined as antipsychotic medication of 3.5 haloperidol
equivalents for 12 weeks or until remission of the psych-
otic symptoms); 6) no neurological or endocrine disorders
with relationship to the psychosis; 7) no contraindications
to antipsychotic medication; 8) understands ⁄ speaks
Norwegian; 9) IQ over 70 measured by the Wechsler
intelligence scales for adults (WAIS) [17]; 10) willing and
able to give informed consent.
The present study is part of the Early Treatment and
Intervention in Psychosis Study-2 (TIPS-2). This is a
continuation of the TIPS study, which was an early de-
tection program that consisted of repeated information
campaigns directed at the general population, schools,
and first-line health care personnel and low threshold
detection clinical teams capable of rapid assessment and
triage [18]. The study was approved by the Regional
Committee for Medical Research Ethics Health Region
West (015.03). Written informed consent was obtained
from all study participants. Parents or legal guardians
gave informed consent for patients younger than 18
years of age. The patients entered the study through the
early TIPS-2 study’s low-threshold detection team, or
were referred to the hospital acute inpatient ward or the
outpatient clinics by local general practitioners or psy-
chiatrists. After a preclinical screening interview, a se-
nior psychiatrist or psychologist examined the patients.Demographics and supplementary information were col-
lected, and the SCID-I interview was conducted.
Altogether, 481 consecutive patients were identified.
Seventy patients were excluded (21 were not registered in
the catchment area, 12 because of poor language skills, 11
because they were younger than 15 years of age, and 6 be-
cause of low IQ; 20 patients were lost for further study
contact and were not asked). Of the 411 remaining pa-
tients, 166 refused participation. The rate of consent to
participate was therefore 60% (246 patients). This report
comprises data from the time of inclusion. All patients
were assessed within a week of contact and assigned to
the standard treatment program, which consisted of an
antipsychotic medication algorithm, multifamily work,
and active outreach-supportive psychotherapy [19].Assessments
Assessment teams consisting of clinically experienced and
trained research personnel carried out all of the assess-
ments. The structured clinical interview for the DSM-IV
(SCID-I) [20] was used for diagnostic purposes. Symptom
levels were measured by the Positive and Negative Syn-
drome Scale score (PANSS) [16]. Symptom domains are
represented by the corresponding PANSS components
(positive, negative, excitement, depressive and cognitive).
Global functioning was measured by the Global Assess-
ment of Functioning Scale (GAF) [15]. The scores were
split into symptom [GAFs] and function [GAFf] scores to
improve psychometric properties [21]. Drug and alcohol
misuse was measured by the Clinicians Rating Scale [22].
The duration of untreated psychosis (DUP) was measured
retrospectively, based on all of the available sources. The
DUP is reported as weeks from onset of psychosis (the
first week with symptoms corresponding to a PANSS
score of 4 on P1, 3, 5, 6 or G9) until the start of adequate
treatment [18,23].
Suicidal behavior was assessed at the index diagnostic
interview, by asking the patients whether they had experi-
enced any suicidal thoughts, plans, or attempts both in the
preceding month and earlier in their lifetime. The highest
reported level of suicidal behavior for the time period was
registered [24]. The variable was dichotomised into severe
suicidality (present or not), where severe suicidality was de-
fined as plans or attempts [23], based on previously shown
high associations between plans, attempts and later com-
pleted suicides [25].
The assessors were all previously trained to reliabel
use of the instruments. Reliability of measurements were
calculated and ranged from fair to very good (DUP, 0.99;
GAFs score, 0.63; GAFf score, 0.88; PANSS positive sum
score, 0.88; PANSS negative sum score, 0.76; and PANSS
general sum score, 0.56 [all intra-class correlations, 1.1];
for diagnostic categories, K = 0.76) [19].
Table 1 Baseline comparison of demographic
characteristics of OCD and non-OCD first episode
psychosis
Variable OCD (N=26) Non-OCD (N=220) P-value
Mean Mean
Age (SD) 22.96 (8,007) 27.05 (10,321) .053*
DUP in weeks mean
(SD)/median
61.3(113.9)/14 80.5 (204.9)/20 .497
Male (%) 43.2 58.6 .112
Single marital status (%) 87.5 74.5 .116
Drug abuse % 15.4 29.8 .122
Years of education
mean (SD)
11.4 (1.7) 11.8 (2.6) .501
DUP = duration of untreated psychosis.
* = Significant at .05 level.
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The diagnostics of OCD were based on a stringent
three-step procedure. The first step was the original
SCID-I interview, which was accomplished by members
of the detection team trained for reliability (for details
see earlier publications; [26,27]). The second step was an
independent review in which the SCID-I and PANSS re-
ports which were a part of each patient’s file, and the pa-
tients’ full medical records were re-assessed. The first
author, a psychologist with extensive training in OCD
diagnostics, performed the reviews. In the third step,
all cases in which obsessions or compulsions were men-
tioned in either PANSS, SCID-I, or in the medical
record, were re-examined jointly by a senior psychiatrist
(T.K.L) and a senior psychologist (B.H), both with exten-
sive experience in diagnostics of OCD and psychosis.
The medical records were electronically stored and we
thus had the ability to search each one for relevant con-
cepts, such as obsessive, compulsive, ritual, exposure
therapy, and SSRI. The diagnostics were based on a strict
definition of OCD, and the obsessive-compulsive symp-
toms had to be unrelated to the psychotic content.
Statistics
Continuous data were presented as means with standard
deviations (SD) and analysed using Students t-test.
Categorical variables were analysed using Chi-square. A
five-factor PANSS component analysis was used to investi-
gate divergences between OCD and non-OCD in dimen-
sions in the PANSS interview [28]. Significance level was
set at P < 0.05. Analyses were performed using SPSS 18.0.
Results
Prevalence of OCD in FEP-patients
Of the 246 participants, 16 patients (6.5%) were originally
diagnosed with OCD, and 10 more cases were diagnosed
with OCD after the reassessment of the OCD diagnostics.
All of the patients initially diagnosed with OCD were diag-
nosed with OCD at the OCD-reassessment. Altogether, 26
patients (10.6%) were found to fulfil the DSM-IV criteria
for OCD.
Comparison of demographic characteristics between OCD
and non-OCD FEP-patients
Table 1 summarises demographic characteristics between
OCD and non-OCD FEP patients. The OCD patients were
younger at start of treatment than their non-OCD coun-
terparts. There were no other significant differences
between the groups.
Comparison of diagnostics between OCD and non- OCD
FEP- patients
Among the patients with schizophrenia spectrum disor-
ders, five patients (5.4%) were diagnosed with co-morbidOCD. This is a significantly lower prevalence than for the
non-schizophrenia spectrum disorders. None of the pa-
tients with schizophrenia were diagnosed with OCD.
Affective psychosis and psychosis-NOS were the diagnoses
with highest prevalence of comorbid OCD (Table 2).
Comparison of clinical symptoms and function
The OCD-patients had more depressive symptoms on the
PANSS, they also had more suicidal plans and attempts
during the last month before hospitalisation. There was,
however no difference in reported lifetime prevalence of
suicidal plans or attempts. There were no significant dif-
ferences between the two groups on the other demograph-
ically characteristics (Table 3).
Discussion
In this study we found the prevalence rate of comorbid
OCD among patients with FEP to be 10.6%. The reported
prevalence is higher than the prevalence of OCD in FEP
in studies by Craig et al. [13], Sim et al. [29], and Sterk
et al. [30]. The independent reassessment of the OCD-
diagnostics raised the prevalence from 6.5% to 10.6%; this
was a procedure that, to our knowledge, was not presented
in other studies of OCD in FEP-patients. Our sample in-
cluded affective psychosis with mood-incongruent delu-
sions in the FEP-sample. Since this was the diagnostic
group with the highest number of OCD-patients in the
sample, the inclusion of this patient group in the sample
may have raised the OCD-prevalence.
Our study indicated a significantly lower comorbidity of
OCD in patients with schizophrenia spectrum disorders.
Most noteworthy is the finding that among the patients
diagnosed with schizophrenia as their primary diagnosis,
none were diagnosed with comorbid OCD. The preva-
lence of OCD for patients diagnosed with schizophrenia
spectrum disorders was in line with the studies from Craig
et al. [13], Sterk et al. [30] and Sim et al. [29], but was
Table 2 Comparison of diagnostics between OCD and
non-OCD in first episode psychosis
Diagnostics OCD (N=26)
N (%)
Non-OCD
(N=220) N (%)
P-value
Schizophrenia spectrum
disorders
5 (19) 87 (40) .043*
Schizophrenia 0 (0) 52 (24)
Schizophreniform
disorder
2 (8) 10 (5)
Schizoaffective disorder 3 (12) 25 (11)
Brief psychosis 0 13 (6)
Delusional disorder 2 (8) 19 (9)
Affective psychosis MID 10 (38) 45 (20)
Psychosis NOS 8 (31) 34 (15)
Drug induced psychotic
disorders
1 (4) 19 (9)
Psychotic disorder NOS 0 3 (1)
* = Significant at .05 level.
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episode schizophrenia spectrum disorders by Poyurovsky
and colleagues [12] and in a study of first episode schizo-
phrenia and related disorders by de Haan [31]. In our
study, OCD was most prevalent among patients with
affective psychosis and psychosis NOS.
The second purpose of the study was to compare
demographic and clinical characteristics between the
OCD and the non-OCD group. The FEP-patients with
OCD were found to have a significantly younger age at the
start of treatment than their non-OCD counterparts. ThisTable 3 Comparison of clinical characteristics of OCD and
non-OCD in first episode psychosis
Variable OCD (N=26) Non-OCD (N=220) P-
value
Mean Mean
GAF Symptoms (SD) 33.1 (5.7) 31.2 (7.4) .138
GAF Function (SD) 40.8 (10.4) 39.5 (9.5) .524
PANSS Total 65.4 (14.1) 64.61 (13.8) .699
Positive component (SD) 14.5 (3.9) 14.5 (3.9) .898
Negative component (SD) 19.7 (8.3) 18.7 (7.3) .542
Excitement component (SD) 8.9 (2.7) 7.9 (3.3) .174
Depressive component (SD) 14.7 (3.1) 12.3 (3.6) .002**
Cognitive symptoms (SD) 5.5 (2.8) 5.8 (2.9) .634
Suicidal behaviour; plans
or attempts (index) (%)
26.9 9.6 .009**
Suicidal behaviour; plans
or attempts (lifetime) (%)
34.6 27.3 .431|
PANSS = Positive and negative symptom scale; GAF = Global Assessment
of Functioning.
**= Significant at .01 level.is in line with the findings from Craig and colleagues [13],
who reported that a significantly larger portions of the
FEP-patients with obsessive compulsive symptoms (OCS)
was younger than 21 years compared to FEP- patients
without comorbid OCS. Poyurovsky and colleagues [32]
reported that adolescent schizophrenia patients with OCD
had an earlier onset of psychosis compared with their
non-OCD counterparts, and Üçok and colleagues [7,11]
reported that among schizophrenia patients, comorbid
OCD was related to earlier debut of schizophrenia. No age
difference in debut of psychosis were found between OCD
and non-OCD patients in hospitalised first-episode schizo-
phrenia patients [12] or in a sample of patients with first-
episode schizophrenia and another related disorder [10].
A possible earlier age of debut, however, is noteworthy
since it may indicate an accentuated neuro-developmental
origin of OCD in patients with psychosis [32].
Patients with co-morbid OCD reported a higher rate of
suicidal plans or attempts at index point. This finding is in
line with the findings from Üçok et al. [7] and Sevincok
et al. [8]. However, this pattern was not reported in a more
recent study by Üçok et al. [11]. A heightened rate of sui-
cidal plans or attempts in the OCD-group is an important
finding, especially given that previous studies have indi-
cated that suicidality at index point is a predictor for con-
tinued suicidality in patients with FEP [23].
The patients with co-morbid OCD scored higher on the
depression component of the PANSS. This in line with
de Haan et al. [31], who reported that, among patients
with recent onset schizophrenia and related disorders, pa-
tients with co-morbid OCD were more depressed, as mea-
sured by the Montgomery-Asberg Depression Rating
Scale (MADRS). The increased prevalence of depressive
symptoms and suicidal plans and attempts may be a result
of living with OCD, which is supported by findings from
Rasmussen & Tsuang [33], who reported that up to 75% of
patients with an OCD diagnosis also fulfilled the criteria
of a depressive disorder. A possible confounding variable
may however be the higher number of patients with
affective psychosis among the patients with comorbid
OCD. Fontenelle et al. [9] argued that depression may
serve as a vulnerability marker for OCD in psychosis since
patients with OCD and psychosis reported a higher rate of
depressive symptoms both before and after conversion
from ultra-high risk for psychosis. The increased depres-
sive symptoms in patients with co-morbid OCD may be
clinically important, given findings that people with psych-
otic disorders and concurrent depressive symptoms have
poorer long-term functional outcomes compared to the
non-depressed [34], and depressive symptoms have been
found to be related to related to an increased risk of
suicidality in FEP-patients [35].
In our study, we found no differences between the OCD
patients and their non-OCD counterparts in total PANSS
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on the five component PANSS analysis [28]. This findings
are in line with the results from de Haan and colleagues
[10], who did not find any significant relationship between
the presence of OCD or OCS and psychotic symptoms in
a sample of patients with first episode schizophrenia and
related disorders. In a recent meta-study of Cunill et al.
[36] they did not report significant differences in PANSS
scores between schizophrenia patients with and without
OCD. The results from our study may support the hy-
pothesis from Berman and colleagues [37] that obsessive-
compulsive symptoms are independent of psychotic
symptoms.
It is difficult to compare studies since the prevalence of
OCD varies significantly, and many studies have selected
samples. A common bias in these estimates of comorbidity
has also been the enrolment of patients with OCS and not
strictly OCD. This has resulted in a gross overestimaton of
co-morbid OCD in many studies [38]. The diagnostics of
OCD in patients in our study were based on strict evalu-
ation of the criteria for OCD, based on the guidelines sug-
gested by Bottas and colleagues [39]. The diagnostics were
made in three independent steps, to ensure the quality of
the assessment. The reassessment of the diagnostics in-
creased the number of OCD-cases from 16 to 26. Interest-
ingly, the re-examination did not reveal any false-positive
OCD cases, which may indicate that false negative results
may be a more problematic issue in diagnostics of OCD
based on SCID-I in FEP-patients than false positive. These
findings indicate that an increased focus on OCD in the
diagnostics of FEP-patients is clinically important. This
may reduce the rate of false negatives, as the diagnostics
with SCID-I may underestimate the prevalence of OCD in
FEP-patients, even when well-trained assessors carry out
the interview. Correct diagnostics are central for optimal
treatment [29,38,40].
The study has several strengths. First, the sample is large
and from a well-defined catchment area. We assume that
nearly every first episode case has been identified and we
regard our sample as being highly representative. Second,
we independently reassessed all the patients for OCD to
ensure the validity of the OCD-diagnostics.
A limitation of the study is that since the primary focus
of the parent study was psychosis, there were no assess-
ment instruments specific to OCD included, such as the
Yale-Brown Obsessive Compulsive Scale [41,42]. Another
limitation is that depressive symptoms were quantified
with a second-order method, the PANSS subscale. A third
limitation is lack of information about prior treatment
(SSRI/CBT) for the patients. It should also be noted that
40% of eligible patients declined to participate, so it is
unknown what their diagnoses were and therefore to what
extent this may affect the representative nature of
the sample.Conclusions
OCD co-occurs with psychotic disorders at a higher rate
than in the general population. The high co-morbidity rate
of OCD reported in patients with psychosis seems not to
be a result of chronic illness, antipsychotic medication, or
institutionalisation, as we evaluated the prevalence of
OCD in a group of FEP-patients with consecutive admis-
sions to a comprehensive early psychosis program.
FEP-patients with OCD tended to have affective dis-
order and psychosis NOS, were younger, had more de-
pressive symptoms, and reported higher rates of suicidal
plans or attempts at the index point. These factors indi-
cate that it is important to detect OCD in FEP-patients.
Proper treatment might prevent poor outcomes [43].
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